Procter & Gamble Health Limited reported earnings results for the third quarter and nine months ended March 31, 2024. For the third quarter, the company reported sales was INR 2,524.8 million compared to INR 3,209.2 million a year ago. Revenue was INR 2,547.5 million compared to INR 3,258.9 million a year ago. Net income was INR 465.6 million compared to INR 591.9 million a year ago. Basic earnings per share from continuing operations was INR 28 compared to INR 35.7 a year ago. Diluted earnings per share from continuing operations was INR 28 compared to INR 35.7 a year ago.
For the nine months, sales was INR 8,673.8 million compared to INR 9,284.4 million a year ago. Revenue was INR 8,808.8 million compared to INR 9,413.7 million a year ago. Net income was INR 1,842 million compared to INR 1,996.5 million a year ago. Basic earnings per share from continuing operations was INR 111 compared to INR 120.3 a year ago. Diluted earnings per share from continuing operations was INR 111 compared to INR 120.3 a year ago.